The most commonly used biomarker in HCC is alpa-feta protein (AFP), but the early diagnosis of HCC still remains a crucial issue currently due to the low sensibility or specificity limitation of AFP 5-7. The gene discussed is AFP; the disease is hepatocellular carcinoma.